KRAS G12C inhibitor 27
KRAS G12C inhibitor 27 is a KRAS G12C inhibitor with antitumor effects (WO2021109737) [1].
Product Specifications
CAS Number
[2648584-51-2]
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-27.html
Solubility
10 mM in DMSO
Smiles
N#CC[C@@H]1N(C(C(F)=C)=O)CCN(C2=C(CO[C@@H](C3=CC=CC=C3C(F)(F)F)C4)C4=NC(OC[C@H]5N(C)CCC5)=N2)C1
Molecular Formula
C29H32F4N6O3
Molecular Weight
588.60
References & Citations
[1]Zusheng Xu, et al. Oxygen-containing heterocyclic compound, preparation method and application thereof. WO2021109737A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6144266-01 0.1 mL
Semaphorin 4D (Semaphorin-4D, SEMA4D, A8, BB18, C9orf164, CD100, coll-4, GR3, M-sema-G, SEMAJ) (Biotin)
Sign In for Pricing
View Details MBS6144266-02 5x 0.1 mL
Semaphorin 4D (Semaphorin-4D, SEMA4D, A8, BB18, C9orf164, CD100, coll-4, GR3, M-sema-G, SEMAJ) (Biotin)
Sign In for Pricing
View Details P6000-87-HRP 100 µL
Pregnancy Associated Plasma Protein A (PAPP-A, Pappalysin 1, PAPA, PAPPA, PAPP-A, PAPPA1, Aspecific BCL2 ARE-binding Protein 2, ASBABP2, Differentially Placenta 1 Expressed Protein, DIPLA1, EC 3.4.24.79, IGF-dependent IGFBP-4 Protease, IGFBP-4ase, Insulin-like Growth Factor-dependent IGF-binding Protein 4 Protease, Pappalysin 1 Precursor) (HRP)
Sign In for Pricing
View Details K7007307 1.0 µg DNA
Rims1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details